drugset / Trial / NCT00985647
Pharmacokinetics of Lamivudine at Two Different Doses
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of the study is to measure the pharmacokinetics (how a drug is absorbed, distributed and eliminated from the body) of lamivudine (3TC) and its active component after 3TC is given at two different doses, 300mg and 150mg once daily.
Timeline
- Start
- 2009-12
- Primary completion
- 2010-02
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lamivudine | Other / unclassified | 150 mg | Oral |
| Comparator | Lamivudine | Other / unclassified | 300 mg | Oral |